Cargando…
KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes
AIMS/HYPOTHESIS: We developed KDT501, a novel substituted 1,3-cyclopentadione chemically derived from hop extracts, and evaluated it in various in vitro and in vivo models of diabetes and insulin sensitivity. METHODS: KDT501 was evaluated for anti-inflammatory effects in monocyte/macrophage cells; a...
Autores principales: | Konda, Veera R., Desai, Anuradha, Darland, Gary, Grayson, Neile, Bland, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907559/ https://www.ncbi.nlm.nih.gov/pubmed/24498211 http://dx.doi.org/10.1371/journal.pone.0087848 |
Ejemplares similares
-
Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans
por: Kern, Philip A., et al.
Publicado: (2017) -
The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans
por: Finlin, Brian S., et al.
Publicado: (2017) -
Rho iso-alpha acids from hops inhibit the GSK-3/NF-κB pathway and reduce inflammatory markers associated with bone and cartilage degradation
por: Konda, Veera Reddy, et al.
Publicado: (2009) -
Optimized mixture of hops rho iso-alpha acids-rich extract and acacia proanthocyanidins-rich extract reduces insulin resistance in 3T3-L1 adipocytes and improves glucose and insulin control in db/db mice
por: Tripp, Matthew L., et al.
Publicado: (2012) -
A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals
por: Lerman, Robert H., et al.
Publicado: (2014)